eCite Digital Repository

The effect of cancer stage and treatment modality on quality of life in oropharyngeal cancer


Oates, J and Davies, S and Roydhouse, J and Fethney, J and White, K, The effect of cancer stage and treatment modality on quality of life in oropharyngeal cancer, Laryngoscope, 124, (1) pp. 151-158. ISSN 0023-852X (2014) [Refereed Article]

Copyright Statement

Copyright 2013 The American Laryngological, Rhinological and Otological Society, Inc.

DOI: doi:10.1002/lary.24136


Objectives/Hypothesis: To examine changes in health-related quality of life among oropharyngeal cancer patients by stages and across treatment types among advanced cancer patients.

Study Design: Individual prospective cohort study.

Methods: All newly diagnosed patients with oropharyngeal cancer treated with curative intent were routinely assessed. The European Organization for Research and Treatment of Cancer (EORTC) both the Main Module quality-of-life questionnaire (QLQ-C30) and the Head and Neck Cancer (HNC) Module (QLQ-H&N35) were administered at diagnosis and 3, 6, and 12 months thereafter. Complete case analysis was used following assessment of missing data. The proportion of patients with clinically significant deterioration (changes of ≥ 10 points) from baseline were calculated for each follow-up time point and compared by stage (I/II vs. III/IV) and then treatment type (chemotherapy and radiotherapy [CRT] vs. surgery and postoperative radiotherapy [S&PORT]).

Results: Deterioration in most domains was most frequent for stage III/IV patients at 3 months (both modules), whereas stage I/II patients experienced this at 6 months (QLQ-C30) and 12 months (H&N35). Among stage III/IV patients, this happened at all time points for S&PORT patients (QLQ-C30) versus 12 months for CRT patients (H&N35). The number of patients reporting deterioration was lower for most domains at 12 months compared to earlier periods, although dry mouth remained a problem for most patients (60%-85% across treatment/stage groups).

Conclusions: Our preliminary findings suggest that general and disease-specific deterioration is of most concern for stage I/II patients at 6 and 12 months and at 3 months for advanced cancer patients. For stage III/IV patients receiving S&PORT, general deterioration remains a problem after diagnosis, whereas for CRT patients, disease-specific deterioration is of most concern at 12 months.

Item Details

Item Type:Refereed Article
Keywords:oropharyngeal cancer, quality of life, surgery, radiotherapy, head and neck cancer
Research Division:Biomedical and Clinical Sciences
Research Group:Oncology and carcinogenesis
Research Field:Oncology and carcinogenesis not elsewhere classified
Objective Division:Health
Objective Group:Evaluation of health and support services
Objective Field:Evaluation of health outcomes
UTAS Author:Roydhouse, J (Dr Jessica Roydhouse)
ID Code:137367
Year Published:2014
Web of Science® Times Cited:12
Deposited By:Menzies Institute for Medical Research
Deposited On:2020-02-11
Last Modified:2020-07-27

Repository Staff Only: item control page